Malignant Cervical Neoplasm — Trials

Malignant Cervical Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

1,994 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 506
Recruiting: 280
Ph III recruiting: 34
Growth YoY: −11.9%
Industry share: 20%
Top sponsor: National Cancer Institute (NCI)
Termination share: 22.7%
Trials / 1,000 deaths: 121.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (181)

clinicaltrialsPublishedShowing 51–81 of 81 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04121975	CCRT Combined With Endostar for the Treatment of Locally Advanced Cervical Cancer	unknown	Phase 2	82	Zhejiang Cancer HospitalOTHER	1	Oct 10, 2019	clinicaltrials
NCT04096911	Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer	unknown	Phase 2	20	Buhai WangOTHER	1	Sep 20, 2019	clinicaltrials
NCT03550755